Table 3.
Co-morbidities in the respondents with and without BA
| Ukraine | Kazakhstan | Azerbaijan | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Respondentsa | Respondentsa | Respondentsa | |||||||
| without BA | with BA | p-value | without BA | with BA | p-value | without BA | with BA | p-value | |
| Valid N | 871 | 70 | 693 | 237 | 817 | 115 | |||
| Any co-morbidity, % | 42.0 | 62.9 | 0.001 | 20.8 | 50.6 | < 0.001 | 51.4 | 77.4 | < 0.001 |
| Hypertension, % | 13.1 | 37.1 | < 0.001 | 21.6 | 40.1 | < 0.001 | 16.2 | 27.0 | 0.006 |
| Diabetes, % | 3.2 | 5.7 | 0.291 | 3.5 | 4.2 | 0.689 | 4.8 | 9.6 | 0.044 |
| Cardiovascular disease, % | 6.0 | 14.3 | 0.013 | 7.0 | 13.9 | 0.001 | 3.5 | 8.7 | 0.015 |
| Abnormal blood lipids, % | 4.3 | 10.0 | 0.039 | 10.0 | 17.3 | 0.004 | 1.0 | 3.5 | 0.050 |
| Depression, % | 0.5 | 1.4 | 0.322 | 0.4 | 0.8 | 0.607 | 1.7 | 3.5 | 0.263 |
| Anxiety, % | 0.2 | 0.0 | 1.000 | 0.6 | 0.4 | 1.000 | 2.6 | 3.5 | 0.758 |
| Osteoporosis, % | 0.6 | 1.4 | 0.374 | 1.5 | 2.5 | 0.384 | 0.5 | 0.9 | 1.000 |
| Tuberculosis, % | 0.5 | 1.4 | 0.321 | 2.2 | 1.7 | 0.794 | 0.7 | 7.0 | < 0.001 |
| Pneumonia, % | 18.9 | 38.6 | < 0.001 | 11.8 | 27.8 | < 0.001 | 5.5 | 12.2 | 0.009 |
| Allergic rhinitis, % | 3.6 | 15.7 | < 0.001 | 5.6 | 21.9 | < 0.001 | 6.9 | 20.9 | < 0.001 |
a Respondents with BA are respondents who reported wheezing symptoms at the ATS Respiratory Symptoms Questionnaire
Percentages are calculated from the number of respondents with valid data (valid N). P-values are for the 2-sided comparison (Chi-square tests) of rates between respondents with and without BA